37 results on '"Lemonnier L"'
Search Results
2. WS10.01 The French Compassionate Programme of elexacaftor/tezacaftor/ivacaftor in people with cystic fibrosis with advanced lung disease and no F508del CFTR variant
3. WS03.04 Survival of people with cystic fibrosis: complete overview in France and first evaluation of the impact of modulators
4. 2-APB inhibits volume-regulated anion channels independently from intracellular calcium signaling modulation
5. A new human gene KCNRG encoding potassium channel regulating protein is a cancer suppressor gene candidate located in 13q14.3
6. Direct modulation of volume-regulated anion channels by Ca 2+ chelating agents
7. 36: International comparison of survival in cystic fibrosis between Canada, France, and Australia
8. WS08.2 Cancer incidence and prevalence among patients with cystic fibrosis: data from the National French Cystic Fibrosis Registry
9. P058 Follow-up before and after lung transplantation for cystic fibrosis: state of the French practices between 2011 and 2017 based on the French Registry
10. ePS2.04 Gastrointestinal surgery in adult patients with cystic fibrosis: observational French prospective study over 11 years
11. WS23.6 Impact of the French high emergency program in cystic fibrosis: survival comparison between France and Canada
12. WS21.3 Overview of shared benefits from the 6-year long collaboration between the French Cystic Fibrosis Registry and the CFTR-France genetics database
13. P064 Comparison of the characteristics of patients enrolled in the 2016 French Cystic Fibrosis Registry according to the value of their sweat test
14. P017 Update of CFTR-France: toward a more relevant dataset for predicting the impact of rare CFTR variants
15. EPS5.02 Estimation of survival of cystic fibrosis patients in France by two different methods
16. WS17.1 The multi-faceted nature of CFTR exonic mutations: impact on their functional classification
17. WS05.5 Pregnancy outcome in women with cystic fibrosis and poor pulmonary function
18. 413 Outcome in children diagnosed with cystic fibrosis via newborn screening 2003–2014
19. EPS7.5 Long-term effects of azithromycin in cystic fibrosis
20. WS14.2 PYOnever study: characteristics of cystic fibrosis adults never colonized by Pseudomonas aeruginosa
21. WS11.3 Cystic fibrosis survival and socioeconomic status across Europe
22. 26 Retrospective observational study of French patients with cystic fibrosis and a G551D mutation after 1 and 2 years of treatment with ivacaftor
23. 4 Valuable collaboration between a molecular CFTR database and a national CF registry: the French experience
24. ePS05.1 CF deaths in France often occurred in the intensive care unit: always justified?
25. WS11.1 The French CF newborn screening: optimization of the programme by a centralized tracking process
26. 296 The French clinical trials network: The National Platform for Clinical Research (NPCR)
27. 302 MucoDoméos: An electronic medical record (SMR) dedicated to the CF patients
28. WS18.1 Towards a better understanding of survival data in CF
29. WS09.8 End-of-life care in CF patients: France, 2007–2010
30. 292 Specific causes of mortality in CF patients in France 2007-2010
31. WS4.2 How different is the cohort of young CF children included in national registries of countries with and without newborn screening?
32. WS18.1 Evolution of pregnancies in the French CF Registry: 1992–2011
33. 343 Transplantation in CF patients in the French CF Registry
34. WS3.2 Who is reported in the Belgian, Dutch and French CF registries?
35. Criteria for diagnosis of CF in the French Registry
36. Perception et diagnostic des patients allergiques aux acariens domestiques : une enquête européenne.
37. The multi-faceted nature of 15 CFTR exonic variations: Impact on their functional classification and perspectives for therapy.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.